Although the absence of a G13 mutation is usually associated with poor prognosis in pancreatic cancer, the presence of a G13 mutation was associated with significantly shorter OS than other KRAS mutations in our full cohort of patients with KRAS+/TP53+ mutations and in those with colorectal cancer. Here, TP53 is linked to pancreatic neoplasm.